NME2 and gastric cancer: However, a metastasis suppressor role of NME2 has been demonstrated in BCa, lung cancer, oral squamous carcinoma, melanoma, gastric cancer, endometrial cancer, HCC, thyroid carcinoma, and osteosarcoma.